Parisa Emami, MD, MPH

Case control study of 80 eyes from patients with autism and 160 from neurotypical controls found inner retina thicker in #autism and correlates with brain volumes #OCT #MRI @ParisaEmamiMD @FatemeMonta3eri @ucdavis ow.ly/iCFz50W6jit

New study highlights racial disparities in healthcare access & quality for patients with #uveitis using the @NIH All of Us Database. Check out the study for more details. @FatemeMonta3eri @ParisaEmamiMD ow.ly/wMbL50UMw52

Parisa Emami-Naeini, MD, MPH, is our final One to Watch of 2024! She is an associate professor of ophthalmology and the director of the Uveitis Service at the Tschannen Eye Institute. Read more about Dr. Emami-Naeini here: bit.ly/4gBcAkB

@FaresAntaki @JordanDeanerMD @ferhina @xephalon @ImanSoltaniPhD Thanks 😊 @FaresAntaki and @pearsekeane

@ParisaEmamiMD @JordanDeanerMD @ferhina @xephalon @ImanSoltaniPhD Nice work!

Hot off the press! Check out our latest publication on the performance of automated machine learning in retina @JordanDeanerMD @ferhina @xephalon @ImanSoltaniPhD

@AAOjournal @ImanSoltaniPhD

Performance of automated machine learning in predicting outcomes of pneumatic retinopexy ow.ly/cSX850QumJN @parisaemamiMD

Register for our @aao_ophth Uveitis Webinar. Case-based discussion including #uveitis trials: FAST, MUST, POINT & MERIT, w/ speakers: Nisha Acharya, MD @proctorfndn Parisa Emami MD @ParisaEmamiMD Douglas Jabs, MD @JohnsHopkinsSPH Shilpa Kodati, MD @ShilpaKodati Arjun Sood, MD

Register today - Feb 8, Fork in the Road: Deciding Which #Uveitis Treatment Is Best, a case-based webinar looking at studies guiding the treatment of uveitis. #CME Free for Academy members #Ophthalmology ow.ly/R0WB50Qli3e

Check our latest 📚in @AAOjournal on disparities in ophthalmology clinical trials. More needs to be done to ensure inclusivity and generalizability🌟 @FatemeMonta3eri @ucd_eyecenter @NatEyeInstitute #ophthalmology #InclusionMatters ophthalmologyscience.org/article/S2666-…

Join us tomorrow to talk about uveitis emergencies and disasters! #aao2023 ⁦@SArepalliMD⁩ ⁦@profnidasen⁩ ⁦@ucd_eyecenter⁩ ⁦@YoungUveitis⁩ ⁦@UveitisSociety⁩

Looking forward to discussing cases with the great faculty tonight!

📢 Join us for the Virtual Grand Rounds on Oct 4th, 8-9 PM EST 🌟 🔍 To submit cases email uveitisgrandrounds@gmail.com by 10/1/23 @SArepalliMD @ShilpaKodati @ucd_eyecenter @EmoryEyeCenter @YoungUveitis @UveitisSociety #MedicalEducation #Uveitis #Ophthotwitter

[REGISTRATION OPEN] Don’t miss your chance to earn #CME credit with this upcoming live-virtual symposium! KOL KNOCKOUT™: Retina Edition - Challenging Cases & Expert Opinions - Round 1. Register here: bit.ly/3EzCAv5

@YoshiYonekawaMD @JeffersonUniv @Wills_Eye @JuliaHallerMD Congrats!

@CuiLab Congrats!🎊🎉

It’s official! We are R01 funded!!!Woohoo 🥳 🥳 🥳 This was 110% a team effort. So many thanks to my mentors, collaborators, supportive colleagues/friends, and current/former Cui lab members 🙏😊

A vascular syphilitic iris lesion sciencedirect.com/science/articl…

Join us on 6/8/23 for another evening of challenging uveitis cases and live discussion. Have a case to discuss? email us at uveitisgrandrounds@gmail.com @SArepalliMD @arthivenkatmd @UveitisSociety @YoungUveitis @ucd_eyecenter @EmoryEyeCenter #ophthalmology

Looking forward to these informative sessions! @YoungMDConnect @ucd_eyecenter

Check out these presentations and sessions by our team @ucd_eyecenter #ARVO2023 @FatemeMonta3eri

Moderated by Drs. @SArepalliMD @EmoryEyeCenter @ParisaEmamiMD @ucd_eyecenter and Dan Brill.